You are here: Info > Legislation > Greek Pharmacovigilance Legislation
You are here: Info > Legislation > Greek Pharmacovigilance Legislation
Electronic reporting requirements for Suspected Unexpected Serious Adverse Reactions (SUSAR) from interventional clinical trials and for spontaneous reports, reports from non-interventional studies or others, including requirements for submission of literature articles to the National Organization for Medicines.